Research On AIDS Vaccine To Begin Next Year In India

New Delhi, November 26: | Updated: Nov 27 2002, 05:30am hrs
The first AIDS vaccine, currently under stage-one of development in the US by Therion Biological Corporation, will be researched for its second phase of development in India during the fourth quarter of 2003, International AIDS Vaccine Initiative (IAVI) president Seth Berkley told FE.

Apart from laying the foundation for a culture of intellectual property rights in the country, IAVI has helped obtain involvement from the World Bank to study new financial mechanisms in the funding of AIDS research, he said after attending a session on investment in health at the Summit .

Joint secretary at the health and family welfare ministry Meenakshi Dutta-Ghosh confirmed that an HIV subtype-C vaccine was already near completion after the government signed a tripartite memorandum of understanding with the Indian Council of Medical Research, IAVI and National Aids Foundation. Ms Ghosh emphasized that the governments national strategy, would generate an onus on social marketing and franchising and the participation of corporations and NGOs in the initiative.

Speaking of the first big boost to non-government efforts in the battle against AIDS, the $100 million effort by Microsoft chief Bill Gates was only a very small part of what was needed, said Bill and Melinda Gates India chief Ashok Alexander. By itself the amount is very small it will work however, to be a catalyst to a larger movement.